Skip to main
PEPG

PepGen Inc (PEPG) Stock Forecast & Price Target

PepGen Inc (PEPG) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

PepGen Inc. is positioned for significant growth, particularly with its Enhanced Delivery Oligonucleotide platform, which has demonstrated promising preclinical results in the transportation of oligonucleotides across various tissues, addressing severe neuromuscular and neurologic diseases. The company has reported a robust splicing correction rate of 53.7% in its pipeline products, exceeding competitors and suggesting substantial efficacy that could lead to improved muscle performance with repeat dosing. As shares are trading around $4 each, there exists meaningful upside potential contingent upon favorable multi-dose data, which could enhance investor sentiment and reflect the company's emerging value in a competitive market.

Bears say

PepGen Inc. is experiencing a negative outlook primarily due to a recent $1 decrease in its targeted stock price, now set at $8 per share, which reflects concerns over its current market valuation relative to its competitors. Despite having promising data from its DM1 product, the company's market cap remains disproportionately low, suggesting market skepticism regarding its future performance. Moreover, challenges in accessing capital markets could hinder its ability to effectively advance its development pipeline, potentially impacting the execution of its commercial strategies and overall viability.

PepGen Inc (PEPG) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of PepGen Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About PepGen Inc (PEPG) Forecast

Analysts have given PepGen Inc (PEPG) a Strong Buy based on their latest research and market trends.

According to 4 analysts, PepGen Inc (PEPG) has a Strong Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

PepGen Inc (PEPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.